JeffreyPopmaMD

Cardiology • Boston, MA

Adult Congenital Heart Disease, Interventional Cardiology

Professor, Medicine-Beth Israel Deaconess Medical Center, Harvard Medical School

Join to view full profile

Dr. Popma is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Popma's full profile

Already have an account?

Office
185 Pilgrim Rd
# BAKER4
Boston, MA 02215
Phone+1 617-632-9210

Fax+1 617-632-7460

Education & Training

University of MichiganFellowship, Cardiovascular Disease, 1989 - 1990
University of Texas Southwestern Medical CenterFellowship, Cardiovascular Disease, 1986 - 1989
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1982 - 1986
University of California (San Francisco)/FresnoInternship, Transitional Year, 1981 - 1982
Indiana University School of MedicineClass of 1981

Certifications & Licensure

MA State Medical License 1998 - 2025
MD State Medical License 1991 - 1999
DC State Medical License 1991 - 1998
MI State Medical License 1989 - 1993
TX State Medical License 1983 - 1989
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Fellow (FACC) American College of Cardiology

Clinical Trials

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2010 Dec 10
Completed
Not Applicable
Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2012 Feb 21
Completed
Not Applicable
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). Start of enrollment: 2012 Apr 01
Active, not recruiting
Not Applicable
Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2012 Aug 01
Active, not recruiting
Frailty Assessment Before Cardiac Surgery & Transcatheter Interventions Start of enrollment: 2012 Jan 01
Completed
Medtronic CoreValve Evolut R U.S. Clinical Study Start of enrollment: 2014 Aug 01
Completed
Not Applicable
Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients Start of enrollment: 2016 Mar 01
Active, not recruiting
Not Applicable
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum) Start of enrollment: 2016 Jun 01
Completed
Not Applicable
Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study Start of enrollment: 2018 Oct 30
Active, not recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis Patients.
Thomas Modine, Didier Tchétché, Nicolas M Van Mieghem, G Michael Deeb, Stanley J Chetcuti
Circulation. Cardiovascular Interventions. 2024-11-01
Heart Failure after Transcatheter Aortic Valve Implantation: Application of the Most Impactful Strain Imaging Techniques.
Gordon M Burke, Jeffrey J Popma, James D Chang
CASE. 2024-01-01
Echocardiographic and Clinical Outcomes in Symptomatic Patients With Less Than Severe Aortic Stenosis After Supra-Annular Self-Expanding Transcatheter Aortic Valve Rep...
Ravi K Sharma, Roger J Laham, Paul Sorajja, Binita Shah, Santiago Garcia
The American Journal of Cardiology. 2023-12-01

Journal Articles

Transcatheter Aortic Valve Replacement in Low-Risk Patients with Bicuspid Aortic Valve Stenosis
John K Forrest, Basel Ramlawi, Neal S Kleiman, Stanley J Chetcuti, Hector I Michelena, Abeel A Mangi, Jeffrey A Skiles, Jeffrey J Popma, Michael J Reardon, JAMA Cardiology
Original Research Self-Expanding Transcatheter Aortic Valve Replacement in Patients with Low-Gradient Aortic Stenosis
Harold L Dauerman, Jon R Resar, Steven J Yakubov, P Michael Grossman, Stanley J Chetcuti, G Michael Deeb, Jeffrey J Popma, Jae K Oh, ScienceDirect
Original Investigation Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients
Jeffrey J Popma, Thomas G Gleason, William H Ryan, Neal S Kleiman, Tanvir Bajwa, David L Brown, ScienceDirect
Clinical Research Trends in Isolated Surgical Aortic Valve Replacement According to Hospital-Based Transcatheter Aortic Valve Replacement Volumes
Jeffrey J Popma, Sammy Elmariah, Robert W Yeh, ScienceDirect
Original Investigation Self-Expanding Transcatheter Aortic Valve Replacement or Surgical Valve Replacement in High-Risk Patients: 5-Year Outcomes
G Michael Deeb, Steven J Yakubov, Joon S Lee, Thomas G Gleason, William Merhi, George Petrossian, G Chad Hughes, David H Adams, Neal S Kleiman, Jeffrey J Popma, Mubash..., ScienceDirect
Frailty Phenotype and Deficit Accumulation Frailty Index in Predicting Recovery After Transcatheter and Surgical Aortic Valve Replacement
Roger J Laham, Jeffrey J Popma, Kamal R Khabbaz, The Journals of Gerontology
Join now to see all

Lectures

Protected PCI: A Contemporary Look at Clinical Data from cVAD
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
Large-Hole Transfemoral Closure I: The PerQseal Device
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
Acquiring Advanced - Complication Management
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/25/2019
Updates From the CoreValve and EVOLUT R Aortic VIV Registries
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
Large-Hole Transfemoral Closure III: The PerQseal Device
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
Fully Absorbable, Patch-Based Large-Hole Vascular Closure Device
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
Case from United States
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
Highlights From the CoreValve Low-Risk Trial
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
Updates in Structural Interventional Cardiology for the CV Team
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
Future of Aortic Valve Surgery in Low-risk Patients: Dilemmas in the Era of Catheter-Based Valve Therapy
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Join now to see all

Press Mentions

Three-Year Data Presented from Medtronic Evolut Low Risk Trial of TAVR Versus SAVRMarch 5th, 2023
Medtronic’s Next-Gen Evolut FX TAVR System Shows Significant Improvement in Commissure Alignment in Real World SettingNovember 30th, 2022
Medtronic’s Newest Self-Expanding TAVR System Linked to Improved PerformanceNovember 29th, 2022
Join now to see all